The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors
暂无分享,去创建一个
Christopher Southan | Stephen PH Alexander | Eamonn Kelly | John A Peters | Elena Faccenda | Adam J Pawson | Joanna L Sharman | Jamie A Davies | Neil Marrion | Helen E Benson | Doriano Fabbro | Stephen P. H. Alexander | C. Southan | D. Fabbro | N. Marrion | J. Davies | E. Faccenda | J. Sharman | H. E. Benson | J. A. Peters | E. Kelly
[1] I. Plaza-Menacho,et al. RET in breast cancer: functional and therapeutic implications. , 2011, Trends in molecular medicine.
[2] D. Tulasne,et al. Met degradation: more than one stone to shoot a receptor down , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Samuel Bouyain,et al. Receptor‐type tyrosine phosphatase ligands: looking for the needle in the haystack , 2013, The FEBS journal.
[4] S. Peters,et al. MET: a promising anticancer therapeutic target , 2012, Nature Reviews Clinical Oncology.
[5] M. Mohammadi,et al. Exploring mechanisms of FGF signalling through the lens of structural biology , 2013, Nature Reviews Molecular Cell Biology.
[6] Johan Lennartsson,et al. Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.
[7] R. Roskoski,et al. Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition. , 2013, Pharmacological research.
[8] Guang Liang,et al. Anticancer molecules targeting fibroblast growth factor receptors. , 2012, Trends in pharmacological sciences.
[9] Matthew B. Dalva,et al. EphBs: an integral link between synaptic function and synaptopathies , 2012, Trends in Neurosciences.
[10] Zhon-Yin Zhang,et al. Small molecule tools for functional interrogation of protein tyrosine phosphatases , 2013, The FEBS journal.
[11] S. Hardy,et al. Inside the human cancer tyrosine phosphatome , 2010, Nature Reviews Cancer.
[12] B. Leitinger,et al. Transmembrane collagen receptors. , 2011, Annual review of cell and developmental biology.
[13] Carlos L. Arteaga,et al. Treatment of HER2-positive breast cancer: current status and future perspectives , 2012, Nature Reviews Clinical Oncology.
[14] Stanley J. Watson,et al. The Fibroblast Growth Factor Family: Neuromodulation of Affective Behavior , 2012, Neuron.
[15] Lydia Tabernero,et al. Protein tyrosine phosphatase structure–function relationships in regulation and pathogenesis , 2013, The FEBS journal.
[16] Hirofumi Inoue,et al. Ectodomain shedding and remnant peptide signalling of EGFRs and their ligands. , 2011, Journal of biochemistry.
[17] N. Ip,et al. Eph receptors at synapses: implications in neurodegenerative diseases. , 2012, Cellular signalling.
[18] Paul H. Huang,et al. Discoidin Domain Receptors: Unique Receptor Tyrosine Kinases in Collagen-mediated Signaling* , 2013, The Journal of Biological Chemistry.
[19] Gou Young Koh,et al. Orchestral actions of angiopoietin-1 in vascular regeneration. , 2013, Trends in molecular medicine.
[20] Mary M. Bendig,et al. HUMANIZED IMMUNOGLOBULIN REACTING WITH α4β7 INTEGRIN , 2010 .
[21] G. Powers,et al. Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2 , 1997 .
[22] H. Baldwin,et al. Role of Tie1 in shear stress and atherosclerosis. , 2011, Trends in cardiovascular medicine.
[23] A. Larsen,et al. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. , 2011, Pharmacology & therapeutics.
[24] G. Paratcha,et al. New insights into the control of neurotrophic growth factor receptor signaling: Implications for nervous system development and repair , 2012, Journal of neurochemistry.
[25] M. Shibuya,et al. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. , 2013, Journal of biochemistry.
[26] Omer Dushek,et al. Non‐catalytic tyrosine‐phosphorylated receptors , 2012, Immunological reviews.
[27] Y. Yamanashi,et al. Activation of receptor protein-tyrosine kinases from the cytoplasmic compartment. , 2012, Journal of biochemistry.
[28] R. Doebele,et al. Treating ALK-positive lung cancer—early successes and future challenges , 2012, Nature Reviews Clinical Oncology.
[29] L. Elferink,et al. Checks and balances: interplay of RTKs and PTPs in cancer progression. , 2011, Biochemical pharmacology.
[30] W. Birchmeier,et al. Targeting MET in cancer: rationale and progress , 2012, Nature Reviews Cancer.
[31] Pradeep J. Nathan,et al. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.
[32] François Guillemot,et al. From Cradle to Grave: The Multiple Roles of Fibroblast Growth Factors in Neural Development , 2011, Neuron.
[33] Carlos F. Ibáñez,et al. p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity , 2012, Trends in Neurosciences.
[34] A. Herington,et al. Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer. , 2013, Biochimica et biophysica acta.